Genomics in Scotland strategy: business and regulatory impact assessment

Business and regulatory impact assessment (BRIA) for the Genomics in Scotland: Building our Future five-year national strategy (2024 to 2029).


11. Legal Aid Impact Test

The strategy is not creating new rights or responsibilities. It is focussed on increasing and improving health care accessibility and our ability to support genomic medicine across Scotland, so should have no impact on the legal aid fund.

Contact

Email: holly.ennis@gov.scot

Back to top